Epilepsy Therapeutics Market - Global Industry Perspective Comprehensive Analysis and Forecast, 2015 to 2021

Report Code: ZMR-91 | Report Format : | Status : Upcoming |

Abstract

Epilepsy is a chronic neurological disorder characterized by unpredictable seizures. Epilepsy is the fourth most common neurological disorder that affects peoples of all age group. Seizures may be classified as focal seizures, generalized seizures, and other seizures. Focal seizures are the most common type of epilepsy which involves secondary generalized tonic/clonic seizures (sGTCS) and complex partial seizures. Generalized seizures include myoclonic seizures, tonic seizures, atonic seizures, absences, and clonic seizures. These seizures occur when neurons in the brain or a group of nerve cells send wrong signals to the body.

Treatment of epilepsies is done by using antiepileptic drugs (AEDs). Antiepileptic drugs are segmented into two major categories namely first generation AEDs and second generation AEDs. Selection of drugs is done by prescriber depending upon the type of seizure, part of brain involved in epilepsy, age of patient.

Epilepsy therapeutic drug market is mostly driven by increasing prevalence of neurological disorders and technological advancements across many countries. Moreover, increasing awareness about diagnostics and treatment of neurological disorders in global market also help in driving the epileptic market growth. Non availability of medical facilities in poor and developing countries can restrict or hinder the growth of epileptic therapeutic market over the years. Conversely, the prescribing pattern of drugs that give preference to first generation AEDs over second generation AEDs is restraining the epilepsy therapeutics market. Nonetheless, ongoing research and development in the healthcare literacy rate are expected to open growth avenues for the market over the years.

The report covers forecast and analysis of the epileptic therapeutic market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Million).  To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the epileptic therapeutic drug market has also been included in the study. The report also analyzes several driving and restraining factors and their impact on the market during the forecast period. The study encompasses a market attractiveness analysis, wherein type segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides detailed segmentation of the epileptic therapeutic drug market based on type and regional segment.

Geographically, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Demand has been analyzed and forecast based on the current trends for the period of six years. North America & Europe were the leading regional segments of the epileptic therapeutic drug market due to availability of second generation antiepileptic drug.

Three new AEDs have been approved in the U.S. since 2012 including ezogabine/retigabine, perampanel and eslicarbazepine acetate. Ezogabine/retigabine and perampanel among these have new mechanism of action and thus it is capturing good amount of market share in the U.S. The epileptic therapeutic market is expected to witness the highest growth in the Asia-Pacific region in the coming years due to high prevalence of epilepsy in India and China, increasing health care infrastructure, incomes and awareness.

Key players in epileptic therapeutic market include Abbott Laboratories, GlaxoSmithKline plc, Cephalon, Inc., Johnson & Johnson, Pfizer, Inc., Novartis AG, Sunovion Pharmaceuticals, Inc.., Valeant Pharmaceuticals International, Inc., Sanofi S.A. and Shire.

This report segments the epileptic therapeutic market are:-

Epilepsy Therapeutics Market: Type Segment Analysis

  • First Generation
  • Second Generation

Epilepsy Therapeutics Market: Regional Segment Analysis

  • North America
  • Europe
  • Asia pacific
  • Latin America
  • Middle east & Africa

Related Reports

Respiratory Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1464 | Report Format:

Global Respiratory Diagnostics Market: Overview People from every corner of the world may have suffered from some kind of respiratory diseases. Respiratory diseases may result in death if they are not properly diagnosed. Commonly prevalent respiratory diseases include asthma, acute respiratory i...Read More

Dermal Filler Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1449 | Report Format:

Global Dermal Filler Market: Overview Treatment for various skin related problems is done through dermal filler procedures. Removal of wrinkles, scars, skin smoothening and other procedures can be done through dermal filler procedure. Though fearing the side effects, the growth in this market ma...Read More

Curcumin Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1412 | Report Format:

Global Curcumin Market: Overview A chemical that is bright yellow in color is curcumin which is produced by some of the plants. It is found in the turmeric. They are mainly sold as food coloring, cosmetic supplement, herbal supplement, and food flavoring. The common application of the curcumin i...Read More

Point-of-Care Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1406 | Report Format:

Global Point-of-Care Diagnostics Market: Overview The point-of-care (POC) diagnostics deals with the medical devices that are used to get immediate outcomes in the investigation of the different diseases such as diabetes, cancer, cardiac diseases, and others. There are different types of POC dev...Read More

Contrast Media/Contrast Agent Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1359 | Report Format:

Global Contrast Media/Contrast Agent Market: Overview To enhance the contrast of the structures or fluids inside the body contrast medium or the contrast agent is used in the medical imaging. The anatomical organs and structures are imaged better as the image contrast is increased. Thus, it is v...Read More

Choose License Type:
Latest Published Reports

View All Published Reports